Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Publikováno v:
Journal of Inflammation Research
Jinghui Lin, Meifang Li, Shijie Chen, Lihong Weng, Zhiyong He Department of Thoracic Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou City, Fujian Province, 350014, People’s Republic of ChinaCorrespondence
Publikováno v:
Journal of Inflammation Research
Jie Gao, Feng Wu, Sifang Wu, Xing Yang Department of Pulmonary and Critical Care Medicine, Huizhou the Third People’s Hospital, Guangzhou Medical College, Huizhou 516002, People’s Republic of ChinaCorrespondence: Sifang Wu; Xing YangHuizhou the T
Autor:
Abbas Yadegar, Fatemeh Gholami, Hamid Asadzadeh Aghdaei, Masoumeh Azimirad, Mohammad Reza Zali, Giovanni Cammarota, Gianluca Ianiro, Shabnam Shahrokh, Hidekazu Suzuki
Publikováno v:
Journal of Inflammation Research. 13:563-570
Purpose Fecal microbiota transplantation (FMT) is an effective treatment option for patients with recurrent Clostridioides difficile infection (rCDI). However, there is a paucity of evidence regarding its efficacy and safety in patients with rCDI and
Publikováno v:
Journal of Inflammation Research. 13:519-531
Janus kinase (JAK) Inhibitors are the latest drug class of disease-modifying medication to emerge for the treatment of rheumatoid arthritis (RA). They are a small molecule-targeted treatment and are the first oral option to compare favourably to exis
Autor:
Hajar Khazraei, Seyyed Mohammad Bagher Fazljou, Mostafa Araj Khodaei, Maryam Ostovan, Mohammadli Torbati
Publikováno v:
Journal of Inflammation Research. 13:369-376
Introduction The mastic tree (Pistacia lentiscus), belonging to the Anacardiaceae family, has anti-inflammatory and antioxidant properties. This study aims to assay the anti-inflammatory effects of mastic in rats with colitis. Methods Forty-eight mal
Autor:
Poonam Gupte, Shital A. Giramkar, Shubhangi Harke, Madhavi P Mahajan, Sneha Keshav Kulkarni, Supriya Bhalerao, Amol Deshmukh, Lal Hingorani
Publikováno v:
Journal of Inflammation Research. 12:145-152
Purpose: Osteoarthritis is the single most common cause of disability in older adults with an estimated 10% to 15% prevalence in individuals above 60 years. The contemporary medications include nonsteroidal anti-inflammatory drugs acetaminophen, cycl
Publikováno v:
Journal of Inflammation Research. 11:35-47
The introduction of anti-tumor necrosis factor (TNF) therapy marked an important milestone in the management of moderate-to-severe Crohn's disease (CD). However, there remains a pressing demand for alternative therapeutic options for patients with pr